Comparing EMDR therapy and SSRIs for treating PTSD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy with Selective Serotonin Reuptake Inhibitors (SSRIs) in treating adults diagnosed with Post-Traumatic Stress Disorder (PTSD). Participants aged 18-60 will be randomly assigned to receive either EMDR therapy or SSRIs for six weeks. The primary outcome will be the rate of remission measured by validated PTSD symptom severity scales at Week 6, while secondary outcomes will assess changes in functional impairment and quality of life. The study aims to evaluate whether EMDR can serve as a non-pharmacological alternative to SSRIs for PTSD symptom relief.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Age 18-60 years

Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD)

Duration of illness ≥ 6 months

Able to provide informed consent

Exclusion Criteria:

Current substance abuse or dependence

History of psychotic disorder or bipolar disorder

Active suicidal ideation

Concurrent psychotherapy or psychiatric medication (except study-assigned SSRI)

Where it's running

• Department of Psychiatry, Combined Military Hospital Nowshera
  Nowshera, Kpk, Pakistan Recruiting
• Combined Military Hospital
  Nowshera, Kpk, Pakistan Not yet recruiting

Study contacts

• Principal investigator: Asad Ullah Jan, MBBS,FCPS — CMH Nowshera
• Study coordinator: Asad Ullah Jan, MBBS, FCPS( Psychiatry)
• Email: asad2097@gmail.com
• Phone: +923445515919

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support

  This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.

  Recruiting at 17 sites Phase 2/3 COMPASS Pathways · Tucson, Arizona and 16 other locations · NCT07570654

• Non-invasive vagus nerve stimulation (gammaCore) for PTSD

  This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.

  Recruiting Acacia Clinics · Sunnyvale, California · NCT07523685

• Virtual Reality–Assisted Trauma-Focused CBT for PTSD

  A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.

  Recruiting Queen's University, Belfast · Newtownabbey, County Antrim · NCT07914634

• ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury

  This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT07890337

• HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

  This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

• Predicting nightmare awakenings in PTSD using an AI algorithm

  The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.

  Recruiting at 2 sites Direction Centrale du Service de Santé des Armées · Brest and 2 other locations · NCT07851480

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.